Drugs / CPG-52852
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00091689 | Sep 2004 → Jan 2006 | melanoma | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT00095160 | Oct 2003 → Jan 2006 | neoplasm | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT00319748 | Apr 2006 → Dec 2007 | breast cancer, cervical cancer, endometrial cancer, ovarian cancer | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
| Phase 2 | NCT00276159 | Jan 2006 → Nov 2008 | Hodgkins lymphoma, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, plasma cell myeloma | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
| Phase 2 | NCT00189332 | Feb 2005 → Aug 2006 | cutaneous melanoma | Pfizer | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00386594 | Oct 2006 → Oct 2010 | Barrett esophagus | Rogers, B.H. Gerald, M.D. | Terminated | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPG-52852 | ChEMBL registry synonym — accepted as the source's own label CHEMBL549344 ↗ |
| Known as | 852A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00189332 ↗ |
| Known as | PF-4878691 | ChEMBL registry synonym — accepted as the source's own label CHEMBL549344 ↗ |
| Action | Activate | “Toll-like receptor 7 agonist” CHEMBL549344 ↗ |
| Modality | Small molecule | — CHEMBL549344 ↗ |
| Route | Topical | “cream directly applied to advanced, inoperable, melanoma skin lesions” NCT00091689 ↗ |
| Target | TLR7 | “Toll-like receptor 7 agonist” CHEMBL549344 ↗ |